BOS Syndrome

BOS syndrome—a very rare genetic (present at birth) condition, most often caused by new (de novo) changes in the ASXL1 gene. Children have a recognizable facial look and a typical bent-arm/bent-wrist posture (“BOS posture”), along with growth and developmental challenges. NCBI+

Bohring–Opitz syndrome is a rare neurodevelopmental disorder that starts before birth. It is usually due to a loss-of-function (truncating) change in one copy of the ASXL1 gene. ASXL1 helps control how DNA is packaged and switched on or off during early development. When ASXL1 does not work properly, many body systems develop differently. Babies may be small before birth, have feeding problems, growth failure, low muscle tone, and a distinct facial appearance. Many children have severe developmental delay, seizures, sleep or breathing problems, and the characteristic bent-arm/bent-wrist posture. NCBI+2MedlinePlus+2

Bohring-Opitz syndrome is a rare genetic condition usually present at birth. It is marked by distinctive facial features, a characteristic flexed-arm posture, feeding difficulty, growth failure, severe developmental delay, and risks such as refractory epilepsy, sleep and breathing problems, and a small but important risk of childhood kidney and (newly recognized) liver tumors. BOS is typically caused by de novo loss-of-function variants in ASXL1 (a chromatin-regulating gene). There is no single curative drug; care focuses on early therapies, nutrition, seizure control, and tumor surveillance (Wilms tumor and hepatoblastoma screening). ARRE Foundation+3NCBI+3PMC+3

Other names

Bohring–Opitz syndrome is also called Oberklaid–Danks syndrome; in medical databases you may see OMIM #605039 or ASXL1-related Bohring–Opitz syndrome. Families and clinicians also use the short name “BOS.” Nature+1

Types

Doctors do not recognize rigid “subtypes,” but they do see variation in severity based on how and where ASXL1 is changed:

• Classic BOS from a de novo truncating ASXL1 variant (most cases).

• Mosaic BOS, when only some body cells carry the variant; this can come from a mosaic parent, which also affects recurrence risk.

• Atypical BOS, when features are present but the look is milder or mixed.
  These patterns reflect the exact ASXL1 change and degree of mosaicism, rather than true, separate types. PubMed+1

Causes

Important note: In BOS, the root cause is loss of function in one copy of the ASXL1 gene. The list below breaks this single root cause into the many biological ways it can happen or act. PubMed+1

1. De novo ASXL1 truncating variant (a new stop/frameshift change in the child; parents do not carry it). This is the most typical cause. PubMed

2. ASXL1 nonsense variant (a “stop” signal appears early in the gene) leading to a short, non-working protein. PubMed

3. ASXL1 frameshift variant (letters added or removed) producing a faulty protein. Wiley Online Library

4. ASXL1 splice-site variant that disrupts normal cutting and joining of RNA, yielding a nonfunctional product. NCBI

5. Parental germline mosaicism (a small fraction of a parent’s eggs/sperm carry the variant), explaining rare recurrence in families. Wiley Online Library

6. Post-zygotic mosaicism in the child (the variant arises after fertilization), so only some tissues carry it. PMC

7. Haploinsufficiency of ASXL1 (one working copy is not enough for normal development). NCBI

8. Disrupted PR-DUB complex (ASXL1 normally teams with BAP1 to remove a tag called H2AK119ub on histone H2A). PMC

9. Chromatin remodeling errors that change how DNA is packed and how genes are read during embryo growth. PMC

10. Dysregulated HOX and developmental gene programs, because ASXL1 helps control these key body-pattern genes. PubMed

11. Imbalance between PRC1/PRC2 and PR-DUB pathways, altering the balance of gene silencing marks (e.g., H2AK119ub, H3K27me3). Nature

12. Enhanced or misdirected BAP1 activity due to mutant ASXL1, leading to abnormal histone marks. SpringerLink

13. Abnormal epigenetic signaling during brain, face, heart, and kidney development. PMC

14. Altered interaction networks of ASXL1 with other chromatin proteins, weakening normal gene control. Science

15. Gene dosage sensitivity of ASXL1-regulated targets in certain tissues (why BOS affects many organs). NCBI

16. Mutant protein effects beyond simple loss (some variants may have “rogue” actions that worsen gene mis-regulation). SpringerLink

17. Developmental timing effects (the gene error happens very early, so many organs are influenced). NCBI

18. Secondary pathway disruptions (e.g., downstream signals that control skull shape, airway tone, or kidney growth). JCI Insight

19. Tissue-specific mosaic patterns (why one child may have stronger features in some body areas). PMC

20. Rare non-ASXL1 contributors in BOS-like cases that intersect with the same chromatin/epigenetic pathway (under study; most proven cases still involve ASXL1). NCBI

Symptoms

1. BOS posture: elbows bent, wrists angled out, fingers flexed. This “fixed” upper-limb posture is a hallmark sign. National Organization for Rare Disorders

2. Feeding problems and poor weight gain in infancy; many need thickened feeds or tube feeds. Orpha.net

3. Failure to thrive and short stature/growth failure over time. NCBI

4. Distinct facial features: full cheeks, synophrys (joined eyebrows), prominent eyes, nevus simplex (pink birthmark) on the forehead/eyelids, small lower jaw. NCBI

5. Head-shape differences: small head (microcephaly) or a pointed forehead (trigonocephaly), sometimes with a prominent metopic ridge. MedlinePlus+1

6. Severe developmental delay and learning disability. Many children remain non-verbal and need full support. MedlinePlus

7. Seizures/epilepsy, often beginning in infancy or early childhood. MedlinePlus

8. Low muscle tone (hypotonia) in infancy; later, tone may increase in some muscles with time. NCBI

9. Breathing problems including sleep apnea or obstructive events. Genetic Rare Disease Center

10. Recurrent respiratory infections or aspiration, especially with feeding difficulties. E-MJM

11. Eye issues (e.g., exposure risk due to prominent eyes; possible refractive errors/strabismus). NCBI

12. Gastroesophageal reflux and constipation are common. National Organization for Rare Disorders

13. Scoliosis or joint contractures, influenced by posture and muscle tone. National Organization for Rare Disorders

14. Kidney and urinary tract differences may occur; importantly, there is a higher risk of Wilms tumor (childhood kidney cancer). Wiley Online Library+1

15. Possible liver tumor risk (hepatoblastoma)—rare, but new data suggest adding liver checks in early childhood. ARRE Foundation

Diagnostic tests

A) Physical examination (bedside observation)

1. Whole-body dysmorphology exam – A clinical geneticist looks for the BOS facial pattern, BOS posture, skin marks, and overall body proportions. This careful look can point strongly toward BOS before genetic testing. NCBI

2. Growth measurements – Plot weight, length/height, and head size over time. BOS often shows prenatal growth restriction and postnatal failure to thrive. Orpha.net

3. Neurologic tone and reflex check – Low tone, delayed milestones, and abnormal reflexes help explain feeding, movement, and breathing issues. NCBI

4. Posture/contracture assessment – Document the classic elbow-wrist-finger posture and any fixed tightness to guide therapy plans. National Organization for Rare Disorders

5. Skin and birthmark review – A midline pink “nevus simplex” on the glabella/eyelids is common and supports the clinical picture. NCBI

B) Manual (non-device) functional tests

6. Bedside feeding/swallowing assessment – A speech-language therapist checks suck, swallow, and breathing coordination to prevent aspiration. Orpha.net

7. Oral-motor exam – Looking at lip seal, tongue movement, and palate function to plan safe feeding strategies. NCBI

8. Developmental screening (e.g., milestone checklists) – Simple, hands-on checks for gross/fine motor, social, and language skills to tailor early therapies. MedlinePlus

9. Range-of-motion testing – Gentle joint movement tests find contractures and guide physiotherapy and splinting. National Organization for Rare Disorders

10. Ophthalmology alignment check (cover–uncover) – A basic in-clinic maneuver helps detect strabismus that can worsen vision if untreated. NCBI

C) Laboratory & pathological/genetic tests

11. Chromosomal microarray – Looks for big missing/extra DNA pieces; helps rule in/out other syndromes and may occasionally detect ASXL1-region changes. BOS is usually single-gene, but microarray is a common first step. NCBI

12. Targeted ASXL1 sequencing – Detects most truncating variants that cause BOS; this is the key confirmatory test. PubMed

13. Trio exome/genome sequencing – Finds ASXL1 variants that targeted tests miss and can detect parental mosaicism when samples from both parents are tested. PubMed

14. DNA methylation “episignature” testing – A blood test that checks a BOS-specific methylation pattern supporting the diagnosis. Nature

15. Tumor-surveillance labs when indicated – For example, alpha-fetoprotein (AFP) during infancy/early childhood when following updated liver-tumor guidance. Lab use is individualized and accompanies imaging (see below). ARRE Foundation

D) Electrodiagnostic tests

16. Electroencephalogram (EEG) – Records brain waves to evaluate seizures or spells that look like seizures. Many BOS children have epilepsy. MedlinePlus

17. Polysomnography (sleep study) – Measures breathing, oxygen, and sleep stages to diagnose sleep apnea, which is reported in BOS. Genetic Rare Disease Center

E) Imaging tests

18. Brain MRI – Looks for structural differences that can explain seizures, tone, or development; findings vary across individuals with BOS. MedlinePlus

19. Abdominal ultrasound for tumor screening – Because BOS raises Wilms tumor risk, expert groups recommend kidney ultrasound every 3 months until age 7–8. New data suggest adding liver imaging to screen for hepatoblastoma in early childhood. Plans are individualized with your genetics/oncology team. Wiley Online Library+2ScienceDirect+2

20. Echocardiogram and renal/bladder ultrasound (as needed) – Some children have heart or kidney/urinary differences; imaging helps detect problems early. NCBI

Non-pharmacological treatments (therapies & other supports)

1. Early developmental intervention (birth–3 years)
   Start coordinated physiotherapy, occupational therapy, and speech/feeding therapy as early as possible. Purpose: maximize neurodevelopment during the most plastic period of the brain. Mechanism: high-frequency, play-based stimulation strengthens motor patterns, posture, oromotor skills, and communication pathways through activity-dependent synaptic change. NCBI

2. Physiotherapy for BOS posture and tone
   Daily range-of-motion, gentle stretching, and positioning target flexion at elbows/wrists and axial hypotonia. Purpose: prevent contractures and support sitting/standing skills. Mechanism: repetitive active-assist movements remodel muscle-tendon length and improve motor unit recruitment. PMC

3. Occupational therapy (fine motor & daily living)
   Customized splints, sensory integration, and task-analysis (grasp, self-care). Purpose: safer feeding, hand use, and participation. Mechanism: graded practice and adaptive equipment shape functional circuits and reduce learned non-use. NCBI

4. Feeding therapy (SLP & OT) with aspiration prevention
   Management includes texture modification, paced feeds, and safe-swallow training; consider thickened liquids when indicated. Purpose: improve weight gain and reduce aspiration. Mechanism: compensatory oromotor strategies and postural adjustments reduce airway penetration during swallowing. National Organization for Rare Disorders

5. Nutrition planning & growth monitoring
   High-calorie, nutrient-dense plans; frequent weight/length tracking; vitamin D and iron status checks per pediatric guidelines. Purpose: address growth failure and micronutrient gaps common in neurodevelopmental disability. Mechanism: tailored caloric/protein targets support linear growth and immune function. National Organization for Rare Disorders

6. Sleep hygiene program
   Regular bedtime, darkness, quiet, and consistent routines. Purpose: reduce sleep fragmentation that worsens daytime tone and seizures. Mechanism: circadian and homeostatic sleep drive consolidation through behavioral cues. (Melatonin is a supplement; dosing variability exists—see cautions below). Health+1

7. Seizure safety education & rescue plan
   Train caregivers to recognize seizure types, use prescribed rescue medicine, and follow an emergency plan. Purpose: faster response and fewer complications. Mechanism: preparedness shortens prolonged seizures and lowers hypoxia risk. National Organization for Rare Disorders

8. Respiratory care & airway clearance
   Positioning, chest physiotherapy, suction training when needed; evaluate obstructive sleep apnea. Purpose: reduce pneumonias related to hypotonia/aspiration. Mechanism: better secretion clearance and airway patency. National Organization for Rare Disorders

9. Orthotics & adaptive seating
   Soft wrist/elbow splints, ankle-foot orthoses, supportive seating systems. Purpose: protect joints and optimize alignment for feeding and communication. Mechanism: external stabilization counteracts dystonic postures and improves biomechanical efficiency. PMC

10. Vision & hearing management
    Routine ophthalmology and audiology visits; early correction of refractive error and hearing loss. Purpose: support language and learning. Mechanism: sensory input optimization enhances downstream cortical development. National Organization for Rare Disorders

11. Tumor surveillance (Wilms tumor & hepatoblastoma)
    Ultrasound kidneys every 3 months in early childhood (Wilms tumor), and—based on 2023–2024 signals—add liver ultrasound ± AFP during infancy/early childhood. Purpose: detect tumors early when cure rates are highest. Mechanism: periodic imaging finds small, asymptomatic masses. IJ Pediatrics+1

12. Dental & oral-motor care
    Desensitization, oral hygiene training, and early dental visits; manage bruxism. Purpose: prevent caries and feeding pain. Mechanism: behavior shaping and fluoride lower bacterial burden. National Organization for Rare Disorders

13. Behavioral therapy & communication supports
    Augmentative and alternative communication (AAC), visual schedules, caregiver coaching. Purpose: reduce frustration and improve communication. Mechanism: external symbol systems leverage intact receptive abilities. National Organization for Rare Disorders

14. Safe mobility & falls prevention
    Home modifications, gait trainers, and caregiver transfer training. Purpose: reduce injuries and hospitalizations. Mechanism: environmental and equipment changes mitigate risk from hypotonia/ataxia. National Organization for Rare Disorders

15. Thermoregulation & skin care
    Layered clothing, hydration, and skin checks given low body fat and immobility. Purpose: avoid hypothermia/pressure sores. Mechanism: proactive management of heat loss and pressure. National Organization for Rare Disorders

16. Constipation program (non-drug first)
    Fiber, fluids, scheduled toileting, abdominal massage. Purpose: reduce pain and reflux exacerbation. Mechanism: stool-softening diet and bowel routines improve colonic transit. (Drug options below if needed.) National Organization for Rare Disorders

17. Vaccination on schedule (plus RSV risk assessment)
    Follow national immunization schedules; discuss RSV prevention eligibility in infancy. Purpose: prevent severe infections that BOS children may tolerate poorly. Mechanism: herd and individual immunity. National Organization for Rare Disorders

18. Social work & family support
    Care coordination, equipment funding, and respite services. Purpose: reduce caregiver burnout and missed care. Mechanism: lowering logistic barriers improves adherence. National Organization for Rare Disorders

19. Genetic counseling
    Clarify recurrence risk, natural history, and emerging research/registries. Purpose: informed family planning and access to trials/resources. Mechanism: expert interpretation of ASXL1 variant and BOS data. NCBI

20. Palliative care (needs-based, not end-of-life only)
    Symptom relief (sleep, pain, feeding) and goal-setting at any stage. Purpose: better quality of life and family coping. Mechanism: interdisciplinary, anticipatory support. National Organization for Rare Disorders

---

Drug treatments

Important: No medicines are FDA-approved specifically for BOS. The drugs below are commonly used to treat symptoms or comorbidities (for example, seizures, reflux, constipation). FDA labels are cited for what the drug is officially approved for in general—not for BOS—and clinicians tailor dosing to the child. Always follow your clinician’s advice.

1. Levetiracetam (Keppra®) – anti-seizure
   Used widely as first-line for focal/generalized seizures due to favorable interaction profile. Class: antiepileptic. Dosage/Time: pediatric dosing is weight-based and titrated; given twice daily. Purpose: reduce seizure frequency and intensity. Mechanism: binds SV2A to modulate neurotransmitter release, stabilizing neuronal firing. Side effects: irritability, somnolence; rare behavior changes—monitor. (FDA-approved for several seizure types; BOS use is off-label.) FDA Access Data

2. Diazepam rectal gel (Diastat®) or intranasal midazolam (Nayzilam®) – rescue for prolonged seizures
   Class: benzodiazepines. Dosage/Time: single rescue dose per weight when a seizure lasts beyond the plan’s threshold; may repeat once per label guidance. Purpose: stop prolonged seizures at home. Mechanism: GABA-A receptor potentiation increases inhibition. Side effects: sedation, respiratory depression (caregiver training essential). (FDA-approved as seizure rescue; BOS use is situational.) FDA Access Data+1

3. Valproic acid (Depakene®) / divalproex – anti-seizure (selected cases)
   Class: broad-spectrum antiepileptic. Dosage/Time: individualized; routine liver and ammonia monitoring. Purpose: control generalized seizures or myoclonus when benefits outweigh risks. Mechanism: increases GABA, modulates sodium/calcium channels. Side effects: hepatotoxicity, thrombocytopenia, weight gain; major teratogenicity—avoid in females of child-bearing potential unless no alternatives. (Label warnings emphasized.) FDA Access Data+1

4. Omeprazole (Prilosec®) – reflux management in significant GERD
   Class: proton pump inhibitor. Dosage/Time: once daily before a meal; pediatric dosing is weight-based and time-limited. Purpose: reduce acid injury, feeding pain, and aspiration risk from reflux. Mechanism: irreversibly inhibits parietal H+/K+-ATPase, lowering gastric acid. Side effects: headache, diarrhea; long-term use needs reassessment. FDA Access Data+1

5. Polyethylene glycol 3350 (PEG) – constipation when diet measures fail
   Class: osmotic laxative. Dosage/Time: daily weight-based powder in liquid; titrate to soft daily stool. Purpose: relieve painful constipation that worsens reflux and feeding. Mechanism: non-absorbable polymer draws water into stool. Side effects: bloating; ensure hydration. (OTC and Rx formulations exist; labels vary.) FDA Access Data

6. Baclofen (oral) – spasticity/dystonia management in selected BOS children
   Class: GABA-B agonist antispasmodic. Dosage/Time: start low, titrate 3×/day; monitor for sedation and hypotonia. Purpose: reduce painful spasms and improve limb positioning. Mechanism: presynaptic inhibition lowers alpha-motor neuron activity. Side effects: drowsiness, constipation; taper to avoid withdrawal. FDA Access Data+1

7. Inhaled bronchodilator or steroid (for co-existing reactive airway)
   Class: SABA or inhaled corticosteroid. Dosage/Time: per pediatric asthma guidelines. Purpose: treat wheeze/airway hyperreactivity that worsens feeding and sleep. Mechanism: smooth muscle relaxation (SABA) or airway anti-inflammation (ICS). Side effects: tremor (SABA); oral thrush (ICS). (Drug-class labels exist; use only if a clinician diagnoses asthma-like disease.) National Organization for Rare Disorders

8. Iron supplementation (if deficiency confirmed)
   Class: mineral supplement (drug or medical food per formulation). Dosage/Time: weight-based elemental iron for 3 months plus diet changes. Purpose: treat anemia/fatigue that can aggravate developmental delay. Mechanism: replenishes iron for hemoglobin and enzymes. Side effects: dark stools, constipation—pair with fiber/PEG as needed. Office of Dietary Supplements

9. Vitamin D (if deficient)
   Class: vitamin supplement. Dosage/Time: per pediatric serum 25-OH-D level; daily cholecalciferol is typical. Purpose: support bone health in non-ambulant children with low sunlight intake. Mechanism: increases calcium absorption/bone mineralization. Side effects: hypercalcemia if overdosed—monitor levels. Office of Dietary Supplements

10. Rescue antipyretics (acetaminophen/ibuprofen)
    Class: analgesic/antipyretic. Dosage/Time: weight-based as needed for fever or pain that disrupts feeding/therapy. Purpose: comfort, better participation in therapies. Mechanism: central COX inhibition (acetaminophen) or peripheral COX inhibition (ibuprofen). Side effects: dosing precision is essential; avoid duplication. (Standard labels apply.) National Organization for Rare Disorders

Notes: Medication choices must be individualized. Some options (e.g., clonazepam, topiramate) may be considered by specialists; growth hormone is not routine in Bloom syndrome because of theoretical tumor risk and is not a BOS therapy—mentioned here only to avoid confusion with prior requests. Always use FDA labels for general safety, but BOS use is off-label. pediatrics.weill.cornell.edu

---

Dietary molecular supplements

1. Vitamin D3 (cholecalciferol) – supports bone and immune function in low levels; dose per labs to avoid toxicity. Mechanism: hormonal regulation of calcium/phosphate; deficiency is common in limited mobility. Office of Dietary Supplements

2. Iron (elemental) – only if iron-deficiency anemia is documented; improves oxygen delivery and development. Mechanism: restores hemoglobin and mitochondrial enzymes. Office of Dietary Supplements

3. Omega-3 fatty acids (EPA/DHA) – may aid cardiometabolic health and neuroinflammation moderation; food sources preferred. Mechanism: membrane composition, eicosanoid balance. Office of Dietary Supplements

4. Coenzyme Q10 (CoQ10) – antioxidant involved in mitochondrial ATP production; clinical benefits in neurodevelopmental disorders are uncertain. Mechanism: electron transport chain cofactor; free-radical buffering. NCBI+1

5. L-Carnitine – for documented deficiency or valproate-associated depletion; supports fatty-acid transport into mitochondria. Mechanism: shuttles long-chain fatty acids into mitochondria for oxidation. Office of Dietary Supplements

6. Calcium (with vitamin D when needed) – supports bone mineralization in low-weight, low-mobility children; dose cautiously. Mechanism: hydroxyapatite formation and signaling. Office of Dietary Supplements

7. Multivitamin tailored to intake – fills general gaps in selective eaters; avoid megadoses. Mechanism: broad micronutrient support to reduce deficiency risk. National Organization for Rare Disorders

8. Probiotics (strain-specific) – may help constipation or antibiotic-associated diarrhea; evidence is strain- and outcome-specific. Mechanism: microbiome modulation and short-chain fatty acid production. National Organization for Rare Disorders

9. Zinc (if deficient) – supports growth, skin, and immune function; test before supplementing to avoid copper imbalance. Mechanism: enzymatic cofactor in growth and healing. National Organization for Rare Disorders

10. Vitamin B12/folate (if low) – correct macrocytic anemia or neuropathy; confirm deficiency first. Mechanism: DNA synthesis and myelin maintenance. National Organization for Rare Disorders

Safety note: Supplements are not FDA-approved drugs; quality can vary (melatonin gummies have labeling inconsistencies). Discuss all supplements with your clinician and use reputable products. Health+1

---

Immunity-booster / regenerative / stem-cell” drugs

There are no FDA-approved “immune-boosting,” regenerative, or stem-cell drugs for BOS. Experimental stem-cell therapies should not be used outside regulated trials. Evidence-based steps to support immunity are vaccination, nutrition, sleep, and infection prevention. In specific cases, clinicians may use:

1. Palivizumab (RSV monoclonal antibody) – only if the infant meets strict criteria (e.g., extreme prematurity or hemodynamically significant heart disease). Passive immunity reduces RSV hospitalizations. Not BOS-specific. National Organization for Rare Disorders

2. Seasonal influenza vaccine & routine immunizations – cornerstone of infection prevention. Mechanism: adaptive immune priming. National Organization for Rare Disorders

3. Iron, vitamin D, zinc (if deficient) – correcting deficiencies supports immune function but is not an “immune booster.” Mechanism: restore normal immune cell metabolism. Office of Dietary Supplements+1

4. Antibody-guided antibiotics – not “boosters,” but targeted therapy for documented infections lowers complications in BOS. Mechanism: eradicates pathogens to reduce systemic stressors. National Organization for Rare Disorders

5. Avoid unproven stem-cell interventions – no BOS indication; risks include infection, graft reactions, and high cost without benefit. Mechanism: unvalidated. National Organization for Rare Disorders

6. Clinical trials – families may consider ethically approved studies via registries/foundations; review risks/benefits carefully. Wiley Online Library

---

Surgeries (what they are & why done)

1. Gastrostomy tube (G-tube)
   Procedure: endoscopic or surgical placement of a feeding tube through the abdominal wall. Why: severe or unsafe oral feeding, aspiration, or failure to thrive despite intensive therapy. National Organization for Rare Disorders

2. Anti-reflux surgery (fundoplication)
   Procedure: wrap upper stomach around the lower esophagus. Why: intractable reflux with aspiration risk not controlled by therapy and medication. National Organization for Rare Disorders

3. Orthopedic soft-tissue releases
   Procedure: targeted tendon lengthening for fixed contractures. Why: improve positioning, hygiene, and comfort when bracing/therapy fail. PMC

4. Airway interventions (e.g., adenotonsillectomy)
   Procedure: remove enlarged tonsils/adenoids. Why: obstructive sleep apnea with desaturation or poor feeding/growth. National Organization for Rare Disorders

5. Tumor surgery
   Procedure: resection if Wilms tumor or hepatoblastoma is detected. Why: potentially curative treatment discovered via surveillance imaging. ARRE Foundation

---

Preventions (day-to-day)

1. Keep vaccinations current. National Organization for Rare Disorders

2. Hand hygiene and illness-exposure reduction. National Organization for Rare Disorders

3. Safe feeding strategies to reduce aspiration. National Organization for Rare Disorders

4. Bowel program to prevent painful constipation. National Organization for Rare Disorders

5. Sleep routine to stabilize seizures and behavior. Health

6. Regular therapy (PT/OT/SLP) to maintain function. NCBI

7. Dental care to prevent caries and pain. National Organization for Rare Disorders

8. Tumor screening on schedule (kidney ± liver in early years). ARRE Foundation

9. Vision/hearing checks to catch treatable issues. National Organization for Rare Disorders

10. Caregiver support to sustain adherence and reduce burnout. National Organization for Rare Disorders

---

When to see doctors (right away or soon)

See your clinician urgently for new or prolonged seizures, breathing difficulty, color change, dehydration, fever with lethargy, vomiting with poor intake, or blood in stool/urine. Arrange prompt visits for feeding regression, weight loss, increased reflux/coughing during feeds, sleep apnea signs (snoring, pauses), constipation not responding to home care, new lumps in the abdomen (tumor concern), or any regression of skills. Regularly scheduled multidisciplinary reviews are key in BOS. National Organization for Rare Disorders

---

What to eat & what to avoid

1. Do emphasize calorie-dense, protein-rich foods (nut butters, dairy/yogurt if tolerated) to support growth. Avoid low-calorie filling snacks that displace needed nutrition. National Organization for Rare Disorders

2. Do include fiber-rich fruits/veg and fluids for bowel health; avoid sudden high-fiber jumps that worsen bloating. National Organization for Rare Disorders

3. Do use thickened liquids or modified textures if prescribed; avoid thin liquids if aspiration is documented. National Organization for Rare Disorders

4. Do ensure vitamin D and calcium adequacy per labs; avoid excessive supplementation without monitoring. Office of Dietary Supplements

5. Do correct iron deficiency with diet/supplements if proven; avoid iron without indication. Office of Dietary Supplements

6. Do prefer omega-3-rich foods (fish, flax) weekly; avoid high-dose oils without clinician input. Office of Dietary Supplements

7. Do small, frequent meals to lessen reflux; avoid large meals near bedtime. FDA Access Data

8. Do keep hydration steady to support bowel regularity; avoid sugary beverages that worsen dental risk. National Organization for Rare Disorders

9. Do consider dietitian guidance for tailored plans; avoid fad or elimination diets without rationale. National Organization for Rare Disorders

10. Do use reputable brands for any supplement; avoid poorly labeled gummies (melatonin labeling can be unreliable). Health+1

---

FAQs

1. Is there a cure for BOS?
   Not yet. Care improves health and development through therapies, nutrition, seizure control, and tumor surveillance; research and registries are ongoing. NCBI+1

2. What causes BOS?
   Usually a new (de novo) pathogenic variant in ASXL1, which regulates gene expression during development; parents typically do not carry it. NCBI

3. How is BOS diagnosed?
   By clinical features plus confirmatory genetic testing demonstrating a pathogenic ASXL1 variant. NCBI

4. What is the tumor risk?
   A small but meaningful childhood risk of Wilms tumor and newly recognized hepatoblastoma, so ultrasound surveillance in early years is advised. IJ Pediatrics+1

5. Are there BOS-specific medicines?
   No. Medicines treat symptoms (seizures, reflux, constipation, spasticity). All are off-label for BOS. NCBI

6. Will my child walk or talk?
   Abilities vary. Many children have severe delays; early, intensive therapies and communication supports (AAC) help each child reach their potential. National Organization for Rare Disorders

7. How often are checkups needed?
   Frequent multidisciplinary visits in infancy/early childhood; follow tumor screening schedules; adjust as needs evolve. NCBI

8. Is feeding by tube common?
   G-tubes are considered when oral feeding is unsafe or inadequate despite therapy; they can improve growth and lower aspiration risk. National Organization for Rare Disorders

9. Do we need a sleep study?
   Yes, if there are apnea signs (snoring, pauses, poor growth). Treating sleep problems improves daytime function and safety. National Organization for Rare Disorders

10. Should we use melatonin for sleep?
    Only with clinician guidance; supplement quality varies and dosing can be inaccurate in gummies—focus first on sleep hygiene. Health+1

11. What about experimental stem-cell therapy?
    Avoid outside regulated trials—no evidence for BOS and potential harm. Ask about legitimate research via registries. Wiley Online Library

12. Will our next child have BOS?
    Recurrence risk is usually low because most variants are de novo, but genetic counseling is recommended to discuss rare scenarios like parental mosaicism. NCBI

13. Are there adult BOS outcomes?
    Data are limited; supportive care continues across the lifespan. Patient registries are expanding knowledge and guidance, including cancer screening updates. Wiley Online Library+1

14. Can therapies really help?
    Yes—while they do not “cure,” early, intensive, goal-directed therapy improves comfort, feeding, communication, and participation. NCBI

15. Where can families find trusted information?
    GeneReviews, rare disease organizations, and clinician-led registries offer vetted, current guidance and community connections. NCBI+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 29, 2025.